You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hu14.18K322A

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pretreatment Anti-Therapeutic Antibodies in Patients Treated

Completed
  • Ewing Family of Tumors
  • +3 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Nov 4, 2020

    Neuroblastoma Trial in Memphis (biological, drug, other, device)

    Completed
    • Neuroblastoma
    • Humanized anti-GD2 antibody
    • +4 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Nov 14, 2018

    Bullous Pemphigoid Trial in Worldwide (biological, other, drug)

    Recruiting
    • Bullous Pemphigoid
    • efgartigimod PH20 SC
    • +2 more
    • Fountain Valley, California
    • +24 more
    Jul 27, 2022

    Plaque Psoriasis Trial in Canada, United States (Roflumilast Cream 0.3%, Roflumilast Cream 0.15%, Vehicle Cream)

    Completed
    Has Results
    • Plaque Psoriasis
    • Roflumilast Cream 0.3%
    • +2 more
    • Beverly Hills, California
    • +29 more
    Aug 31, 2022

    Brodalumab in Plaque Psoriasis to Understand Impact on Quality

    Recruiting
    • Psoriasis
    • Brodalumab
    • Matched cohort
    • Calgary, Alberta, Canada
    • +33 more
    Oct 8, 2022

    Ganglioneuroblastoma, Nodular, Neuroblastoma Trial in Worldwide (Dinutuximab, Irinotecan, Isotretinoin)

    Active, not recruiting
    • Ganglioneuroblastoma, Nodular
    • Neuroblastoma
    • Dinutuximab
    • +4 more
    • Mesa, Arizona
    • +77 more
    Aug 17, 2022

    Generalized Myasthenia Gravis Trial in Worldwide (efgartigimod PH20 SC)

    Active, not recruiting
    • Generalized Myasthenia Gravis
    • efgartigimod PH20 SC
    • Carlsbad, California
    • +46 more
    Jul 5, 2022

    Melanoma Trial in Madison (hu14.18-IL2)

    Completed
    Has Results
    • Melanoma
    • Madison, Wisconsin
      University of Wisconsin Hospitals and Clinics
    Nov 13, 2019

    Multiple Sclerosis, Relapsing-Remitting Trial in Worldwide (GA Depot, Placebo)

    Active, not recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • GA Depot
    • Placebo
    • Birmingham, Alabama
    • +111 more
    Aug 11, 2021

    Neuroblastoma Trial in Los Angeles (Dinutuximab with Chemotherapy)

    Not yet recruiting
    • Neuroblastoma
    • Dinutuximab with Chemotherapy
    • Los Angeles, California
      Childrens Hospital Los Angeles
    Jun 13, 2022

    Pemphigus Vulgaris, Pemphigus Foliaceus Trial in Worldwide (efgartigimod PH20 SC, prednisone)

    Recruiting
    • Pemphigus Vulgaris
    • Pemphigus Foliaceus
    • Birmingham, Alabama
    • +120 more
    Dec 22, 2022

    Plaque Psoriasis Trial in Canada, United States (Roflumilast)

    Completed
    • Plaque Psoriasis
    • Beverly Hills, California
    • +29 more
    Oct 4, 2021

    Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma Trial in Worldwide

    Active, not recruiting
    Has Results
    • Localized Resectable Neuroblastoma
    • +5 more
    • Aldesleukin
    • +6 more
    • Birmingham, Alabama
    • +196 more
    Dec 30, 2022

    AF Analysis Software in AF Rhythm Monitoring

    Recruiting
    • Atrial Fibrillation
    • Atrial Fibrillation Paroxysmal
    • ECG/PPG monitoring
    • Beijing, Beijing, China
    • +1 more
    Oct 13, 2022

    Generalized Myasthenia Gravis Trial in Worldwide (efgartigimod PH20 SC, efgartigimod IV)

    Completed
    • Generalized Myasthenia Gravis
    • efgartigimod PH20 SC
    • efgartigimod IV
    • Carlsbad, California
    • +46 more
    Jan 31, 2022

    Acne Vulgaris Trial in Canada, United States (IDP-126 Gel, IDP-126 Component A, IDP-126 Component B)

    Completed
    Has Results
    • Acne Vulgaris
    • IDP-126 Gel
    • +4 more
    • Hot Springs, Arkansas
    • +33 more
    Oct 13, 2021

    Pemphigus Vulgaris, Pemphigus Foliaceus Trial in Worldwide (biological, other, drug)

    Recruiting
    • Pemphigus Vulgaris
    • Pemphigus Foliaceus
    • efgartigimod PH20 SC
    • +2 more
    • Birmingham, Alabama
    • +130 more
    Dec 22, 2022

    High Risk Neuroblastoma, Recurrent Neuroblastoma, Refractory Neuroblastoma Trial in Worldwide (Dinutuximab, Eflornithine

    Recruiting
    • High Risk Neuroblastoma
    • +2 more
    • Dinutuximab
    • +4 more
    • Birmingham, Alabama
    • +141 more
    Dec 28, 2022

    Prostate Cancer, Magnetic Resonance Imaging, Population at Risk Trial in Lake Success (Bi-parametric MRI)

    Recruiting
    • Prostate Cancer
    • +2 more
    • Bi-parametric MRI
    • Lake Success, New York
      Cynthia Knauer
    Aug 26, 2022

    Lung Cancer, Lung; Node Trial (CT scans 2D Reconstruction, CT scans 2D plus 3D Reconstruction)

    Not yet recruiting
    • Lung Cancer
    • Lung; Node
    • CT scans 2D Reconstruction
    • CT scans 2D plus 3D Reconstruction
    • (no location specified)
    Jan 27, 2023

    Psoriatic Plaque Trial in Canada, United States (ESR-114, Placebo)

    Completed
    • Psoriatic Plaque
    • Santa Monica, California
    • +9 more
    Jul 27, 2020

    Ulcerative Colitis Trial in Worldwide (cobitolimod, Placebo)

    Completed
    Has Results
    • Ulcerative Colitis
    • Prague, Czechia
    • +63 more
    Jan 12, 2021

    Breast Cancer Trial in Worldwide (trastuzumab, docetaxel, lapatinib ditosylate)

    Active, not recruiting
    Has Results
    • Breast Cancer
    • trastuzumab
    • +3 more
    • Anchorage, Alaska
    • +257 more
    Feb 28, 2022

    Breast Cancer Female Trial in São Paulo (adjuvant ultra-hypofractionated radiotherapy)

    Completed
    • Breast Cancer Female
    • adjuvant ultra-hypofractionated radiotherapy
    • São Paulo, Brazil
      Instituto de Pesquisa Prevent Senior
    Apr 30, 2023

    Seborrheic Dermatitis Trial in Canada, United States (ARQ-154 - Active, ARQ-154 Vehicle)

    Completed
    • Seborrheic Dermatitis
    • ARQ-154 - Active
    • ARQ-154 Vehicle
    • Scottsdale, Arizona
    • +52 more
    Aug 4, 2022